Exosome Diagnostic And Therapeutic Market Expected to Achieve 28% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Exosome Diagnostic And Therapeutic Market Size By 2025?
The market size of exosome diagnostic and therapeutic has witnessed tremendous growth over the past few years. Its size is projected to increase from $0.47 billion in 2024 to $0.6 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 29.3%. This significant growth during the historic period is due to advancements in biological research, proliferation of precision medicine, breakthroughs in biomedical imaging, progression in cancer research and oncology, and considerable investments in the healthcare industry.

How Big Is the Exosome Diagnostic And Therapeutic Market Size Expected to Grow by 2029?
The market size for exosome diagnostics and therapeutics is anticipated to experience significant expansion in the coming years. It's projected to attain a value of $1.62 billion by 2029, at a compound annual growth rate (CAGR) of 28.0%. Factors contributing to the growth during the forecast period include an increase in clinical applications, integration with digital health technology, a favorable regulatory environment, developments in gene editing and RNA therapies, and an enhanced role in immuno-oncology. Key trends in the forecast period comprise drug discovery based on exosomes, biomimetic exosome engineering, exosome product commercialization, exosome-equipped therapeutic cargo, and liquid biopsy for cancer detection.

View the full report here:
https://www.thebusinessresearchcompany.com/report/exosome-diagnostic-and-therapeutic-global-market-report

Which Key Market Drivers Powering Exosome Diagnostic And Therapeutic Market Expansion and Growth?
The escalating occurrence of chronic diseases is anticipated to boost the expansion of the exosome diagnostic and therapeutic market in the future. Suffering from a chronic disease means enduring a condition that prolongs for three months or more, and it may worsen over time. The diagnostic and therapeutic roles of exosomes serve as potential biomarkers in cancer, offering more accurate monitoring of the disease, thereby making personalized healthcare more accessible. For example, by January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, forecasts that by 2050, chronic diseases will afflict a staggering 142.66 million people globally. Hence, the mounting occurrence of chronic diseases is steering the growth of the exosome diagnostics and therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12346&type=smp

Which Emerging Trends Are Transforming the Exosome Diagnostic And Therapeutic Market in 2025?
In the exosome diagnostic and therapeutic market, mainstream companies are striving to innovate, developing products like sample purification systems to widen their customer reach, bolster sales, and boost revenue. For example, in February 2023, Biological Dynamics Inc., a biotech firm based in the US, introduced ExoVerita, a platform developed for early disease detection and other uses. This platform has an ExoVita Pancreas assay which can identify specific exosomal protein markers and has been verified to detect Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) through the analysis of blood-derived exosome samples processed in the ExoVerita system. This validation will be used on samples from the ExoLuminate registry trial (NCT05625529) which is geared towards patients with high-risk PDAC to estimate the clinical significance of this test. Individuals eligible for this trial include those exhibiting clinical symptoms like pancreatitis or known pancreatic lesions, genetically predisposed individuals, and newly diagnosed diabetics above the age of 50.

What Are the Emerging Segments in the Exosome Diagnostic And Therapeutic Market?
The exosome diagnostic and therapeutic market covered in this report is segmented -

1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users

Subsegments:
1) By Instruments: Exosome Isolation Systems, Characterization Instruments, Analysis Devices
2) By Software: Data Analysis Software, Exosome Profiling Software, Laboratory Management Software
3) By Reagents And KITS: Isolation KITS, Characterization Reagents, Assay KITS

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12346&type=smp

Who Are the Global Leaders in the Exosome Diagnostic And Therapeutic Market?
Major companies operating in the exosome diagnostic and therapeutic market include Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc., Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

Which are the Top Profitable Regional Markets for the Exosome Diagnostic And Therapeutic Industry?
North America was the largest region in the exosome diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12346

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.